GlassScriptPhysician profile
Katelyn C Boren
NPI 1740821941
$9,532.38
in general payments reported to CMS, 2019-2025
37 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,236 · 2022: $3,868 · 2023: $1,143 · 2024: $1,555 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,260 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,260.31 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,403.04 | 2021-2025 | Urolift |
| Pfizer INC. | $1,029.31 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $706.61 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $698.41 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $668.26 | 2021-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $664.08 | 2021-2025 | Provenge |
| Axonics, INC. | $459.71 | 2021-2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $459.14 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $411.17 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Boston Scientific Corporation | $377.68 | 2022-2025 | Lumenis Pulse 120h, General - Erectile Dysfunction, Axonics |
| Urogen Pharma, INC. | $372.97 | 2021-2025 | |
| Myovant Sciences INC. | $274.50 | 2021-2022 | |
| Janssen Biotech, INC. | $269.99 | 2021-2025 | Erleada |
| Procept Biorobotics Corporation | $254.98 | 2023-2025 | Aquabeam Robotic System |
| 180 Medical, INC. | $182.08 | 2022-2025 | Gentlecath, Cure Catheter |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $177.93 | 2021-2022 | |
| Cook Medical LLC | $142.97 | 2022 | |
| Myriad Genetic Laboratories, INC. | $134.47 | 2022-2024 | Prolaris |
| Laborie Medical Technologies Corp. | $96.19 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $80.06 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $69.87 | 2021-2025 | |
| Tolmar, INC. | $67.37 | 2023-2025 | Eligard, Jatenzo |
| Abbvie INC. | $59.03 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $58.32 | 2021-2023 | Xiaflex |
| Rochester Medical Corporation | $45.05 | 2021 | |
| Verity Pharmaceuticals INC. | $44.92 | 2022-2023 | Trelstar |
| Urovant Sciences INC | $44.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $40.66 | 2022-2023 | Lynparza |
| Immunitybio, INC. | $37.91 | 2025 | |
| Ferring Pharmaceuticals INC. | $33.93 | 2024-2025 | Adstiladrin |
| Halozyme INC | $31.67 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $31.25 | 2022 | |
| Alnylam Pharmaceuticals INC. | $28.90 | 2021 | |
| Blue Earth Diagnostics | $24.25 | 2022 | |
| Hollister Incorporated | $18.90 | 2022 | |
| Endo USA, INC. | $18.69 | 2024 | Xiaflex |
| Calyxo, INC. | $13.77 | 2025 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Boren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.